ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,106 | -3.9% | 2,557 | +50.6% | 0.00% | – |
| Q2 2023 | $8,439 | +250.0% | 1,698 | +248.0% | 0.00% | – |
| Q1 2023 | $2,411 | -88.5% | 488 | -85.3% | 0.00% | – |
| Q4 2022 | $20,946 | -61.2% | 3,330 | -32.4% | 0.00% | – |
| Q3 2022 | $54,000 | -14.3% | 4,923 | -10.1% | 0.00% | – |
| Q2 2022 | $63,000 | +80.0% | 5,474 | +41.9% | 0.00% | – |
| Q1 2022 | $35,000 | -16.7% | 3,858 | +35.5% | 0.00% | – |
| Q4 2021 | $42,000 | +200.0% | 2,848 | +420.7% | 0.00% | – |
| Q3 2021 | $14,000 | -94.8% | 547 | -94.7% | 0.00% | -100.0% |
| Q2 2021 | $271,000 | -26.0% | 10,410 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $366,000 | +5128.6% | 10,368 | +3390.9% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 297 | +494.0% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 50 | -31.5% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 73 | +46.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |